Coffee Consumption After Laparoscopic Hysterectomy
COFFEE-LH
Effect of Postoperative Coffee Consumption on Bowel Motility and Length of Hospital Stay Following Laparoscopic Hysterectomy: A Randomized Controlled Trial
1 other identifier
interventional
50
1 country
1
Brief Summary
Postoperative ileus and delayed bowel recovery remain common concerns following laparoscopic hysterectomy despite enhanced recovery protocols. Coffee consumption has been suggested as a simple, safe, and inexpensive intervention that may stimulate gastrointestinal motility and accelerate postoperative recovery. This randomized controlled trial aims to evaluate the effect of postoperative coffee consumption on bowel function recovery and length of hospital stay in women undergoing laparoscopic hysterectomy. Eligible participants are randomly assigned to either a coffee intervention group receiving standard postoperative care plus coffee at predetermined postoperative time points or a control group receiving standard postoperative care alone. The primary objective is to determine whether postoperative coffee consumption improves bowel recovery and shortens hospitalization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 12, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 25, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 25, 2025
CompletedFirst Submitted
Initial submission to the registry
June 29, 2026
CompletedFirst Posted
Study publicly available on registry
July 7, 2026
CompletedJuly 7, 2026
July 1, 2026
6 months
June 29, 2026
July 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time to First Passage of Flatus
Time from the end of surgery to the first passage of flatus, recorded in hours.
From the end of surgery until the first passage of flatus, assessed for up to 72 hours after surgery.
Secondary Outcomes (3)
Time to First Defecation
From the end of surgery until the first bowel movement, assessed for up to 72 hours after surgery.
Time to First Bowel Sounds
From the end of surgery until the first bowel sounds are detected, assessed for up to 72 hours after surgery.
Length of Hospital Stay
From the date of surgery until hospital discharge, assessed for up to 5 days after surgery.
Study Arms (2)
Coffee Group
EXPERIMENTALParticipants received standard postoperative care plus 100 mL of soluble coffee prepared with hot water at postoperative 6, 12, and 18 hours.
Control Group
NO INTERVENTIONParticipants received standard postoperative care according to institutional clinical practice without postoperative coffee consumption.
Interventions
Participants received 100 mL of hot soluble coffee prepared with hot water at postoperative hours 6, 12, and 18 in addition to standard postoperative ERAS care.
Eligibility Criteria
You may qualify if:
- Women aged 18 years or older.
- Scheduled for elective laparoscopic hysterectomy.
- Able to consume oral fluids according to the ERAS protocol.
- Able to communicate in Turkish.
- Willing to participate and provide written informed consent.
You may not qualify if:
- Emergency surgery.
- Known allergy or intolerance to coffee or caffeine.
- Gastrointestinal diseases or conditions affecting bowel motility.
- Postoperative complications requiring intensive care or preventing oral intake.
- Withdrawal of informed consent at any stage of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Bağcılar Training and Research Hospital
Istanbul, 34810, Turkey (Türkiye)
Study Officials
- PRINCIPAL INVESTIGATOR
Müzeyyen Ataseven, PhD,RN
Istanbul Medipol University, Faculty of Health Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcomes assessor/statistician who performed the data analysis was blinded to group allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD, RN, Principal Investigator
Study Record Dates
First Submitted
June 29, 2026
First Posted
July 7, 2026
Study Start
May 12, 2025
Primary Completion
October 25, 2025
Study Completion
October 25, 2025
Last Updated
July 7, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared. The study did not include a data-sharing plan, and participant confidentiality will be maintained.